首页 > 最新文献

Cancer Investigation最新文献

英文 中文
Development and Validation of a Nomogram for Prognosis Prediction in Patients with Synchronous Primary Thyroid and Breast Cancer Based on SEER Database. 基于 SEER 数据库的同步原发性甲状腺癌和乳腺癌患者预后预测提名图的开发与验证
IF 1.8 4区 医学 Q3 Medicine Pub Date : 2024-03-01 Epub Date: 2024-03-25 DOI: 10.1080/07357907.2024.2329963
Miao Huo, Jianfei Zhang, Minna Hou, Jianhui Li, Ning Bai, Ruifen Xu, Jiao Guo

This study aimed to develop prognostic prediction models for patients diagnosed with synchronous thyroid and breast cancer (TBC). Utilizing the SEER database, key predictive factors were identified, including T stage of thyroid cancer, T stage of breast cancer, M stage of breast cancer, patient age, thyroid cancer surgery type, and isotope therapy. A nomogram predicting 5-year and 10-year survival rates was constructed and validated, exhibiting strong performance (C-statistic: 0.79 in the development cohort (95% CI: 0.74-0.84), and 0.82 in the validation cohort (95% CI: 0.77-0.89)). The area under the Receiver Operator Characteristic (ROC) curve ranged from 0.798 to 0.883 for both cohorts. Calibration and decision curve analyses further affirmed the model's clinical utility. Stratifying patients into high-risk and low-risk groups using the nomogram revealed significant differences in survival rates (P < 0.0001). The successful development and validation of this nomogram for predicting 5-year and 10-year survival rates in patients with synchronous TBC hold promise for similar patient populations, contributing significantly to cancer research.

本研究旨在为确诊为同步甲状腺癌和乳腺癌(TBC)的患者建立预后预测模型。利用 SEER 数据库,确定了关键的预测因素,包括甲状腺癌 T 分期、乳腺癌 T 分期、乳腺癌 M 分期、患者年龄、甲状腺癌手术类型和同位素治疗。构建并验证了预测5年和10年生存率的提名图,该提名图表现出很高的性能(C统计量:开发队列为0.79(95% CI:0.74-0.84),验证队列为0.82(95% CI:0.77-0.89))。两个队列的接收者特征曲线(ROC)下面积均为 0.798 至 0.883。校准和决策曲线分析进一步证实了该模型的临床实用性。使用提名图将患者分为高风险组和低风险组,发现生存率有显著差异(P
{"title":"Development and Validation of a Nomogram for Prognosis Prediction in Patients with Synchronous Primary Thyroid and Breast Cancer Based on SEER Database.","authors":"Miao Huo, Jianfei Zhang, Minna Hou, Jianhui Li, Ning Bai, Ruifen Xu, Jiao Guo","doi":"10.1080/07357907.2024.2329963","DOIUrl":"10.1080/07357907.2024.2329963","url":null,"abstract":"<p><p>This study aimed to develop prognostic prediction models for patients diagnosed with synchronous thyroid and breast cancer (TBC). Utilizing the SEER database, key predictive factors were identified, including T stage of thyroid cancer, T stage of breast cancer, M stage of breast cancer, patient age, thyroid cancer surgery type, and isotope therapy. A nomogram predicting 5-year and 10-year survival rates was constructed and validated, exhibiting strong performance (C-statistic: 0.79 in the development cohort (95% CI: 0.74-0.84), and 0.82 in the validation cohort (95% CI: 0.77-0.89)). The area under the Receiver Operator Characteristic (ROC) curve ranged from 0.798 to 0.883 for both cohorts. Calibration and decision curve analyses further affirmed the model's clinical utility. Stratifying patients into high-risk and low-risk groups using the nomogram revealed significant differences in survival rates (<i>P</i> < 0.0001). The successful development and validation of this nomogram for predicting 5-year and 10-year survival rates in patients with synchronous TBC hold promise for similar patient populations, contributing significantly to cancer research.</p>","PeriodicalId":9463,"journal":{"name":"Cancer Investigation","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140287000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Nature, Origin, and Evolution of Life: Part III the Emergence of Complex Life. 生命的本质、起源和进化:第三部分复杂生命的出现。
IF 1.8 4区 医学 Q3 ONCOLOGY Pub Date : 2024-03-01 Epub Date: 2023-11-17 DOI: 10.1080/07357907.2023.2281715
Gary H Lyman, Christopher H Lyman, Nicole M Kuderer
{"title":"The Nature, Origin, and Evolution of Life: Part III the Emergence of Complex Life.","authors":"Gary H Lyman, Christopher H Lyman, Nicole M Kuderer","doi":"10.1080/07357907.2023.2281715","DOIUrl":"10.1080/07357907.2023.2281715","url":null,"abstract":"","PeriodicalId":9463,"journal":{"name":"Cancer Investigation","volume":null,"pages":null},"PeriodicalIF":1.8,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71478355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Concurrent Use of Crocin During Chemoradiation for Esophageal Squamous Cell Carcinoma. 食管鳞状细胞癌化疗期间同时使用克罗霉素的随机、双盲、安慰剂对照临床试验
IF 2.4 4区 医学 Q3 Medicine Pub Date : 2024-02-01 Epub Date: 2024-02-22 DOI: 10.1080/07357907.2024.2319754
Nima Ebrahimi, Seyed Alireza Javadinia, Roham Salek, Azar Fanipakdel, Samaneh Sepahi, Mansoureh Dehghani, Niloufar Valizadeh, Seyed Ahmad Mohajeri

Crocin is the major active carotenoid of saffron (Crocus sativus L.). Its pluripotent effects have led to a growing body of literature investigating its antitumor properties as well as its diverse potentials for mood stabilization, normal tissue protection, and inflammation reduction; However, there is a gap in clinical trials testing this substance in cancer patients. In this randomized, double-blind, placebo-controlled clinical trial, patients with newly diagnosed esophageal squamous cell carcinoma were randomly assigned to either 30 mg/day of crocin or placebo, prescribed during the neoadjuvant chemo-radiotherapy. The primary endpoints were pathological response and toxicity, and secondary endpoints were depression and anxiety levels and survival analysis.

藏红花素是藏红花(Crocus sativus L.)的主要活性类胡萝卜素。由于藏红花具有多能效应,越来越多的文献研究了它的抗肿瘤特性以及稳定情绪、保护正常组织和减少炎症的多种潜力;然而,在癌症患者中测试这种物质的临床试验还存在空白。在这项随机、双盲、安慰剂对照临床试验中,新确诊的食管鳞状细胞癌患者被随机分配到每天服用 30 毫克的巴豆苷或安慰剂,并在新辅助放化疗期间服用。主要终点是病理反应和毒性,次要终点是抑郁和焦虑水平以及生存分析。
{"title":"Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Concurrent Use of Crocin During Chemoradiation for Esophageal Squamous Cell Carcinoma.","authors":"Nima Ebrahimi, Seyed Alireza Javadinia, Roham Salek, Azar Fanipakdel, Samaneh Sepahi, Mansoureh Dehghani, Niloufar Valizadeh, Seyed Ahmad Mohajeri","doi":"10.1080/07357907.2024.2319754","DOIUrl":"10.1080/07357907.2024.2319754","url":null,"abstract":"<p><p><i>Crocin</i> is the major active carotenoid of saffron (Crocus sativus L.). Its pluripotent effects have led to a growing body of literature investigating its antitumor properties as well as its diverse potentials for mood stabilization, normal tissue protection, and inflammation reduction; However, there is a gap in clinical trials testing this substance in cancer patients. In this randomized, double-blind, placebo-controlled clinical trial, patients with newly diagnosed esophageal squamous cell carcinoma were randomly assigned to either 30 mg/day of crocin or placebo, prescribed during the neoadjuvant chemo-radiotherapy. The primary endpoints were pathological response and toxicity, and secondary endpoints were depression and anxiety levels and survival analysis.</p>","PeriodicalId":9463,"journal":{"name":"Cancer Investigation","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139930198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Nature, Origin and Evolution of Life: Part II The Origin of Life. 生命的本质、起源、发展和进化:第二部分生命的起源。
IF 2.4 4区 医学 Q3 Medicine Pub Date : 2024-02-01 Epub Date: 2023-10-18 DOI: 10.1080/07357907.2023.2270277
Gary H Lyman, Christopher H Lyman, Nicole M Kuderer
{"title":"The Nature, Origin and Evolution of Life: Part II The Origin of Life.","authors":"Gary H Lyman, Christopher H Lyman, Nicole M Kuderer","doi":"10.1080/07357907.2023.2270277","DOIUrl":"10.1080/07357907.2023.2270277","url":null,"abstract":"","PeriodicalId":9463,"journal":{"name":"Cancer Investigation","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41192055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NGS-based Tissue-Blood TMB Comparison and Blood-TMB Monitoring in Stage-III Non-Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy. 基于 NGS 的组织-血液 TMB 比较和血液-TMB 监测在同时接受化疗放疗的 III 期非小细胞肺癌中的应用。
IF 2.4 4区 医学 Q3 Medicine Pub Date : 2024-02-01 Epub Date: 2024-02-23 DOI: 10.1080/07357907.2024.2316297
Luxi Ye, Xiao Chu, Jianjiao Ni, Li Chu, Xi Yang, Zhengfei Zhu

In this study, we analyzed the blood-based TMB (b-TMB) and its dynamic changes in patients with locally advanced non-small cell lung cancer (LA-NSCLC) who received concurrent chemoradiotherapy. Baseline tissue and blood TMB from 15 patients showed a strong positive correlation (Pearson correlation = 0.937), and nearly all mutations were markedly reduced in the later course of treatment, indicating a treatment-related response. This study suggests that in patients with LA-NSCLC, b-TMB is a reliable biomarker, and its dynamic monitoring can help distinguish patients who might benefit most from the consolidated immunotherapy.

在这项研究中,我们分析了同时接受放化疗的局部晚期非小细胞肺癌(LA-NSCLC)患者的血液TMB(b-TMB)及其动态变化。15例患者的基线组织TMB和血液TMB显示出很强的正相关性(Pearson correlation = 0.937),几乎所有的突变在后期治疗过程中都明显减少,表明存在治疗相关反应。这项研究表明,在LA-NSCLC患者中,b-TMB是一种可靠的生物标志物,对其进行动态监测有助于区分哪些患者可能从综合免疫疗法中获益最多。
{"title":"NGS-based Tissue-Blood TMB Comparison and Blood-TMB Monitoring in Stage-III Non-Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy.","authors":"Luxi Ye, Xiao Chu, Jianjiao Ni, Li Chu, Xi Yang, Zhengfei Zhu","doi":"10.1080/07357907.2024.2316297","DOIUrl":"10.1080/07357907.2024.2316297","url":null,"abstract":"<p><p>In this study, we analyzed the blood-based TMB (b-TMB) and its dynamic changes in patients with locally advanced non-small cell lung cancer (LA-NSCLC) who received concurrent chemoradiotherapy. Baseline tissue and blood TMB from 15 patients showed a strong positive correlation (Pearson correlation = 0.937), and nearly all mutations were markedly reduced in the later course of treatment, indicating a treatment-related response. This study suggests that in patients with LA-NSCLC, b-TMB is a reliable biomarker, and its dynamic monitoring can help distinguish patients who might benefit most from the consolidated immunotherapy.</p>","PeriodicalId":9463,"journal":{"name":"Cancer Investigation","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139930197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Review on Emerging Techniques for Diagnosis of Colorectal Cancer. 大肠癌诊断新技术综述。
IF 2.4 4区 医学 Q3 Medicine Pub Date : 2024-02-01 Epub Date: 2024-02-26 DOI: 10.1080/07357907.2024.2315443
Shruthi Nagainallur Ravichandran, Diptimayee Das, Erica Katriel Dayananda, Amit Dey, Antara Banerjee, Alexander Sun-Zhang, Hong Zhang, Xiao-Feng Sun, Surajit Pathak

Common detection methods in practice for diagnosing colorectal cancer (CRC) are painful and invasive leading to less participation of individuals for CRC diagnosis. Whereas, improved or enhanced imaging systems and other minimally invasive techniques with shorter detection times deliver greater detail and less discomfort in individuals. Thus, this review is a summary of the diagnostic tests, ranging from the simple potential use in developing a flexible CRC treatment to the patient's potential benefits in receiving less invasive procedures and the advanced treatments that might provide a better assessment for the diagnosis of CRC and reduce the mortality related to CRC.

诊断结肠直肠癌(CRC)的常用检测方法既痛苦又具有创伤性,导致较少人参与 CRC 诊断。而经过改进或增强的成像系统和其他微创技术检测时间更短,能提供更多细节,减少患者的不适感。因此,这篇综述总结了各种诊断测试,从开发灵活的 CRC 治疗方法的简单潜在用途,到患者接受微创手术的潜在益处,以及可能为 CRC 诊断提供更好评估并降低 CRC 相关死亡率的先进治疗方法。
{"title":"A Review on Emerging Techniques for Diagnosis of Colorectal Cancer.","authors":"Shruthi Nagainallur Ravichandran, Diptimayee Das, Erica Katriel Dayananda, Amit Dey, Antara Banerjee, Alexander Sun-Zhang, Hong Zhang, Xiao-Feng Sun, Surajit Pathak","doi":"10.1080/07357907.2024.2315443","DOIUrl":"10.1080/07357907.2024.2315443","url":null,"abstract":"<p><p>Common detection methods in practice for diagnosing colorectal cancer (CRC) are painful and invasive leading to less participation of individuals for CRC diagnosis. Whereas, improved or enhanced imaging systems and other minimally invasive techniques with shorter detection times deliver greater detail and less discomfort in individuals. Thus, this review is a summary of the diagnostic tests, ranging from the simple potential use in developing a flexible CRC treatment to the patient's potential benefits in receiving less invasive procedures and the advanced treatments that might provide a better assessment for the diagnosis of CRC and reduce the mortality related to CRC.</p>","PeriodicalId":9463,"journal":{"name":"Cancer Investigation","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139971034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective Analyses of PD-L1, LAG-3, TIM-3, OX40L Expressions and MSI Status in Gastroenteropancreatic Neuroendocrine Neoplasms. 胃肠胰神经内分泌肿瘤中 PD-L1、LAG-3、TIM-3、OX40L 表达和 MSI 状态的回顾性分析
IF 2.4 4区 医学 Q3 Medicine Pub Date : 2024-02-01 Epub Date: 2024-03-14 DOI: 10.1080/07357907.2024.2330102
Fatih Gürler, Selin Aktürk Esen, Bediz Kurt İnci, Osman Sütçüoğlu, Gökhan Uçar, Orhun Akdoğan, Doğan Uncu, Nesrin Turhan, Nalan Akyürek, Nuriye Özdemir, Ahmet Özet, Ozan Yazıcı

We investigated expressions of PD-L1, LAG-3, TIM-3, and OX40L as immune checkpoint proteins, and MSI (repetitive short-DNA-sequences due to defective DNA-repair system) status were analyzed with immunohistochemistry from tissue blocks. Of 83 patients, PD-L1 expression was observed in 18.1% (n = 15) of the patients. None of the patients exhibited LAG-3 expression. TIM-3 expression was 4.9% (n = 4), OX40L was 22.9% (n = 19), and 8.4% (n = 7) of the patients had MSI tumor. A low-to-intermediate positive correlation was observed between PD-L1 and TIM-3 expressions (rho: 0.333, p < 0.01). Although PD-L1 expression was higher in grade 3 NET/NEC, MSI status was prominent in grade 1/2 NET.

我们调查了作为免疫检查点蛋白的 PD-L1、LAG-3、TIM-3 和 OX40L 的表达情况,并通过组织块的免疫组化分析了 MSI(DNA 修复系统缺陷导致的重复短 DNA 序列)状态。在 83 例患者中,18.1% 的患者(n = 15)有 PD-L1 表达。没有患者出现 LAG-3 表达。TIM-3表达率为4.9%(n = 4),OX40L表达率为22.9%(n = 19),8.4%(n = 7)的患者患有MSI肿瘤。PD-L1和TIM-3的表达呈中低度正相关(rho:0.333, p
{"title":"Retrospective Analyses of PD-L1, LAG-3, TIM-3, OX40L Expressions and MSI Status in Gastroenteropancreatic Neuroendocrine Neoplasms.","authors":"Fatih Gürler, Selin Aktürk Esen, Bediz Kurt İnci, Osman Sütçüoğlu, Gökhan Uçar, Orhun Akdoğan, Doğan Uncu, Nesrin Turhan, Nalan Akyürek, Nuriye Özdemir, Ahmet Özet, Ozan Yazıcı","doi":"10.1080/07357907.2024.2330102","DOIUrl":"10.1080/07357907.2024.2330102","url":null,"abstract":"<p><p>We investigated expressions of PD-L1, LAG-3, TIM-3, and OX40L as immune checkpoint proteins, and MSI (repetitive short-DNA-sequences due to defective DNA-repair system) status were analyzed with immunohistochemistry from tissue blocks. Of 83 patients, PD-L1 expression was observed in 18.1% (n = 15) of the patients. None of the patients exhibited LAG-3 expression. TIM-3 expression was 4.9% (n = 4), OX40L was 22.9% (n = 19), and 8.4% (n = 7) of the patients had MSI tumor. A low-to-intermediate positive correlation was observed between PD-L1 and TIM-3 expressions (rho: 0.333, <i>p</i> < 0.01). Although PD-L1 expression was higher in grade 3 NET/NEC, MSI status was prominent in grade 1/2 NET.</p>","PeriodicalId":9463,"journal":{"name":"Cancer Investigation","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140130793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting EGFR and VEGFR-2 Kinases With Nanoparticles: A Computational Approach for Cancer Therapy Advancement. 用纳米粒子靶向表皮生长因子受体和血管内皮生长因子受体-2激酶:促进癌症治疗的计算方法》。
IF 2.4 4区 医学 Q3 Medicine Pub Date : 2024-02-01 Epub Date: 2024-03-14 DOI: 10.1080/07357907.2024.2328529
Ibrahim Khater, Aaya Nassar

The study investigates titanium and zinc nanoparticles as inhibitors for the epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor-2 (VEGFR-2), pivotal regulators of cell processes. VEGFR-2 activation fuels tumor angiogenesis in cancer cells, sustaining malignant tissue expansion. Molecular docking analysis illustrates the nanoparticles' binding to the active sites, inhibiting the phosphorylation of key proteins in downstream signaling. This inhibition offers a promising therapeutic approach to impede cancer-related signaling, potentially slowing down aberrant protein cascades controlled by EGFR and VEGFR-2. The findings propose a novel avenue for cancer treatment, targeting abnormal growth pathways using titanium and zinc nanoparticles.

该研究调查了作为表皮生长因子受体(EGFR)和血管内皮生长因子受体-2(VEGFR-2)抑制剂的钛和锌纳米粒子。VEGFR-2 的激活促进了癌细胞中肿瘤血管的生成,使恶性组织持续扩张。分子对接分析表明,纳米粒子能与活性位点结合,抑制下游信号传导过程中关键蛋白的磷酸化。这种抑制作用为阻碍与癌症有关的信号传导提供了一种很有前景的治疗方法,有可能减缓由表皮生长因子受体和血管内皮生长因子受体-2控制的异常蛋白级联。研究结果为癌症治疗提供了一条新途径,即利用钛锌纳米粒子靶向异常生长途径。
{"title":"Targeting EGFR and VEGFR-2 Kinases With Nanoparticles: A Computational Approach for Cancer Therapy Advancement.","authors":"Ibrahim Khater, Aaya Nassar","doi":"10.1080/07357907.2024.2328529","DOIUrl":"10.1080/07357907.2024.2328529","url":null,"abstract":"<p><p>The study investigates titanium and zinc nanoparticles as inhibitors for the epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor-2 (VEGFR-2), pivotal regulators of cell processes. VEGFR-2 activation fuels tumor angiogenesis in cancer cells, sustaining malignant tissue expansion. Molecular docking analysis illustrates the nanoparticles' binding to the active sites, inhibiting the phosphorylation of key proteins in downstream signaling. This inhibition offers a promising therapeutic approach to impede cancer-related signaling, potentially slowing down aberrant protein cascades controlled by EGFR and VEGFR-2. The findings propose a novel avenue for cancer treatment, targeting abnormal growth pathways using titanium and zinc nanoparticles.</p>","PeriodicalId":9463,"journal":{"name":"Cancer Investigation","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140130794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immune Cell Infiltration Types as Biomarkers for the Recurrence Diagnosis and Prognosis of Bladder Cancer. 作为膀胱癌复发诊断和预后生物标志物的免疫细胞浸润类型
IF 2.4 4区 医学 Q3 Medicine Pub Date : 2024-02-01 Epub Date: 2024-02-23 DOI: 10.1080/07357907.2024.2308161
Hongwei Xu, Dapeng Sun, Dahong Zhou, Shiheng Sun

This study aimed to investigate the role of infiltrating immune cell types in diagnosing and predicting bladder cancer recurrence. This study mainly applied some algorithms, including Estimate the Proportion of Immune and Cancer Cells (EPIC), support vector machine-recursive feature elimination (SVM-RFE), random forest out-of-bag (RF-OOB) and least absolute shrinkage and selection operator (LASSO)-Cox regression analysis. We found six immune infiltrating cell types significantly associated with recurrence prognosis and two independent clinical prognostic factors. Infiltrating immune cell types (IICTs) based on the prognostic immune risk score (pIRS) models may provide significant biomarkers for the diagnosis and prognostic prediction of bladder cancer recurrence.

本研究旨在探讨浸润免疫细胞类型在诊断和预测膀胱癌复发中的作用。本研究主要应用了一些算法,包括免疫细胞和癌细胞比例估计(EPIC)、支持向量机-递归特征消除(SVM-RFE)、随机森林外袋(RF-OOB)和最小绝对收缩和选择算子(LASSO)-Cox回归分析。我们发现六种免疫浸润细胞类型与复发预后显著相关,并发现两个独立的临床预后因素。基于预后免疫风险评分(pIRS)模型的浸润免疫细胞类型(ICTs)可为膀胱癌复发的诊断和预后预测提供重要的生物标志物。
{"title":"Immune Cell Infiltration Types as Biomarkers for the Recurrence Diagnosis and Prognosis of Bladder Cancer.","authors":"Hongwei Xu, Dapeng Sun, Dahong Zhou, Shiheng Sun","doi":"10.1080/07357907.2024.2308161","DOIUrl":"10.1080/07357907.2024.2308161","url":null,"abstract":"<p><p>This study aimed to investigate the role of infiltrating immune cell types in diagnosing and predicting bladder cancer recurrence. This study mainly applied some algorithms, including Estimate the Proportion of Immune and Cancer Cells (EPIC), support vector machine-recursive feature elimination (SVM-RFE), random forest out-of-bag (RF-OOB) and least absolute shrinkage and selection operator (LASSO)-Cox regression analysis. We found six immune infiltrating cell types significantly associated with recurrence prognosis and two independent clinical prognostic factors. Infiltrating immune cell types (IICTs) based on the prognostic immune risk score (pIRS) models may provide significant biomarkers for the diagnosis and prognostic prediction of bladder cancer recurrence.</p>","PeriodicalId":9463,"journal":{"name":"Cancer Investigation","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139930196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conceptualization of Breast Cancer and Attitudes toward Breast Cancer Screening: A Qualitative Study on Iranian and Australian Women. 乳腺癌的概念和对乳腺癌筛查的态度:伊朗和澳大利亚妇女的定性研究。
IF 2.4 4区 医学 Q3 Medicine Pub Date : 2024-01-01 Epub Date: 2024-02-12 DOI: 10.1080/07357907.2023.2283866
Tina Parsamand, Fariba Zarani, Leili Panaghi, Cannas Kwok

Objective: Regular screening can lead to early diagnosis of breast cancer. Australia is one of the countries with a high rate of participation in breast cancer screening, while in Iran, most patients are diagnosed in advanced stages. This qualitative study used a thematic analysis method to examine the attitudes and beliefs of Iranian and Australian women toward breast cancer and breast cancer screening.

Method: In-depth interviews were conducted with eight Iranian and seven Australian women. Data were collected through semi-structured interviews and analyzed using thematic analysis with an inferential approach.

Results: According to the results, four main themes were extracted for the perceptions of breast cancer, including "the meaning of breast cancer", "causes of breast cancer", "prevention of breast cancer" and "effects of significant people in life". Considering the perceptions of breast cancer screening, three themes were identified, including "beliefs about breast cancer screening," "sources of information about breast cancer screening," and "barriers to breast cancer screening."

Conclusion: Cultural and social factors influence women's perceptions of breast cancer and screening. Therefore, investigating the cultural meaning of breast cancer and breast cancer screening for women can be useful for screening and prevention purposes.

目的:定期筛查有助于乳腺癌的早期诊断。澳大利亚是参与乳腺癌筛查率较高的国家之一,而在伊朗,大多数患者被诊断为晚期。本定性研究采用专题分析方法,考察伊朗和澳大利亚妇女对乳腺癌和乳腺癌筛查的态度和信念。方法:对8名伊朗妇女和7名澳大利亚妇女进行深度访谈。通过半结构化访谈收集数据,并使用主题分析和推理方法进行分析。结果:根据结果,提炼出“乳腺癌的意义”、“乳腺癌的成因”、“乳腺癌的预防”、“生命中重要人物的影响”四个主题对乳腺癌的认知。考虑到对乳腺癌筛查的看法,确定了三个主题,包括“对乳腺癌筛查的信念”、“乳腺癌筛查信息的来源”和“乳腺癌筛查的障碍”。结论:文化和社会因素影响女性对乳腺癌和筛查的认识。因此,研究乳腺癌和女性乳腺癌筛查的文化意义有助于筛查和预防。
{"title":"Conceptualization of Breast Cancer and Attitudes toward Breast Cancer Screening: A Qualitative Study on Iranian and Australian Women.","authors":"Tina Parsamand, Fariba Zarani, Leili Panaghi, Cannas Kwok","doi":"10.1080/07357907.2023.2283866","DOIUrl":"10.1080/07357907.2023.2283866","url":null,"abstract":"<p><strong>Objective: </strong>Regular screening can lead to early diagnosis of breast cancer. Australia is one of the countries with a high rate of participation in breast cancer screening, while in Iran, most patients are diagnosed in advanced stages. This qualitative study used a thematic analysis method to examine the attitudes and beliefs of Iranian and Australian women toward breast cancer and breast cancer screening.</p><p><strong>Method: </strong>In-depth interviews were conducted with eight Iranian and seven Australian women. Data were collected through semi-structured interviews and analyzed using thematic analysis with an inferential approach.</p><p><strong>Results: </strong>According to the results, four main themes were extracted for the perceptions of breast cancer, including \"the meaning of breast cancer\", \"causes of breast cancer\", \"prevention of breast cancer\" and \"effects of significant people in life\". Considering the perceptions of breast cancer screening, three themes were identified, including \"beliefs about breast cancer screening,\" \"sources of information about breast cancer screening,\" and \"barriers to breast cancer screening.\"</p><p><strong>Conclusion: </strong>Cultural and social factors influence women's perceptions of breast cancer and screening. Therefore, investigating the cultural meaning of breast cancer and breast cancer screening for women can be useful for screening and prevention purposes.</p>","PeriodicalId":9463,"journal":{"name":"Cancer Investigation","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138046174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cancer Investigation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1